Fountainhead Investment Partners is a venture capital firm focused on investments in technologies in the areas of medical devices, multicellular biologic sciences and regenerative medicine. The firm identifies early stage companies that are looking to challenge the stagnation in the medical industry. The company is led by entrepreneurs that work with portfolio companies on operations strategies and management guidance. Portfolio investments range from $250,000 to $1.5 million.
Fountainhead was originally founded as an angel fund in 2014 by a group of healthcare entrepreneurs with a vision to connect advancing technologies to solve some of the most complex issues in medicine. Fountainhead transitioned into a venture capital firm in 2015.